Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

The idea is to supplement this protein with a subcutaneous injection ... process for human testing in 2025. Current diabetes research has mainly focused on improving insulin sensitivity—how ...

Although Type 1 Diabetes Mellitus (T1DM) has a lower number of cases compared to other forms of diabetes, it is often diagnosed at a young age and requires lifelong exogenous insulin administration.

PUTRAJAYA: The Health Ministry (MOH) will still be able to prescribe human insulin to patients until the end of the year, assured its minister Datuk Seri Dr Dzulkefly Ahmad. This was despite the ...

The publication introduces the FITTER Forward Expert Recommendations, an updated set of global best practices for insulin injection technique and education. Authored by a panel of 16 diabetes ...

The publication introduces the FITTER Forward Expert Recommendations, an updated set of global best practices for insulin injection technique and education. Authored by a panel of 16 diabetes ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.